Employee benefit plans (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Share-Based Payment Arrangement [Abstract] |
|
| schedule of share-based compensation, Performance Stock Units Award Activity [Table Text Block] |
A summary of the Company’s PSU activity for the year ended December 31, 2025 is as follows: | | | | | | | | | | | | | Shares (in thousands) | | Weighted-average grant date fair value | | Non-vested shares at December 31, 2024 | 286 | |
| $ | 6.06 | | | Granted | 2,208 | | | 0.63 | | | Vested | (221) | | | 6.14 | | | Forfeited | (2,226) | | | 0.67 | | | Non-vested shares at December 31, 2025 | 47 | | | $ | 5.79 | |
|
| Schedule of Share-based Compensation, Stock Options, Activity |
A summary of the Company’s stock option activity for the year ended December 31, 2025 is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Shares (in thousands) | | Weighted-average exercise price | | Weighted-average remaining contractual term (in years) | | Aggregate intrinsic value (in thousands) | | Outstanding at December 31, 2024 | 2,327 | | | $ | 7.43 | | | 4.59 | | $ | — | | | Granted | — | | | — | | | | | | | Exercised | — | | | — | | | | | | | Forfeited/Cancelled | (883) | | | 8.03 | | | | | | | Outstanding at December 31, 2025 | 1,444 | | | $ | 7.06 | | | 3.24 | | $ | — | | | | | | | | | | | Vested and expected to vest at December 31, 2025 | 1,444 | | | $ | 7.06 | | | 3.24 | | $ | — | | | Exercisable at December 31, 2025 | 1,436 | | | $ | 7.05 | | | 3.22 | | $ | — | |
The weighted-average grant date fair value of all options granted was zero, zero, and $2.14 per share in 2025, 2024, and 2023, respectively. The total fair value of all options vested was $0.5 million, $0.8 million, and $1.4 million in 2025, 2024, and 2023, respectively.
|
| Schedule of Share-based Compensation, Restricted Stock Units Award Activity |
A summary of the Company’s RSU activity for the year ended December 31, 2025 is as follows: | | | | | | | | | | | | | Shares (in thousands) | | Weighted-average grant date fair value | | Non-vested shares at December 31, 2024 | 11,243 | | | $ | 3.38 | | | Granted | 6,963 | | | 0.83 | | | Vested | (6,171) | | | 3.32 | | | Forfeited | (2,120) | | | 2.52 | | | Non-vested shares at December 31, 2025 | 9,915 | | | $ | 1.81 | |
|
| Allocation of Stock-based Compensation Expense |
The following table summarizes stock-based compensation expense included in the consolidated statements of operations: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | (in thousands) | | | | | 2025 | | 2024 | | 2023 | | Cost of revenue | | | | | $ | 946 | | | $ | 1,343 | | | $ | 1,955 | | | Research and development | | | | | 10,393 | | | 14,411 | | | 19,062 | | | Sales and marketing | | | | | 3,533 | | | 5,804 | | | 8,736 | | | General and administrative | | | | | 4,670 | | | 7,574 | | | 11,726 | | | Total stock-based compensation expense | | | | | $ | 19,542 | | | $ | 29,132 | | | $ | 41,479 | |
Total stock-based compensation expense includes accrued stock bonus expense of $2.1 million for the year ended December 31, 2025. Total stock-based compensation expense included no accrued stock bonus expense for the year ended December 31, 2024 or 2023.
|